These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11751067)

  • 1. Increased risk of osteoporotic fractures in patients with Cushing's syndrome.
    Vestergaard P; Lindholm J; Jørgensen JO; Hagen C; Hoeck HC; Laurberg P; Rejnmark L; Brixen K; Kristensen LØ; Feldt-Rasmussen U; Mosekilde L
    Eur J Endocrinol; 2002 Jan; 146(1):51-6. PubMed ID: 11751067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
    Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
    Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.
    Belaya ZE; Hans D; Rozhinskaya LY; Dragunova NV; Sasonova NI; Solodovnikov AG; Tsoriev TT; Dzeranova LK; Melnichenko GA; Dedov II
    Arch Osteoporos; 2015; 10():44. PubMed ID: 26608406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome.
    Ohmori N; Nomura K; Ohmori K; Kato Y; Itoh T; Takano K
    Endocr J; 2003 Feb; 50(1):1-7. PubMed ID: 12733704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
    Folkestad L
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease.
    Di Somma C; Colao A; Pivonello R; Klain M; Faggiano A; Tripodi FS; Merola B; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 1998 May; 48(5):655-62. PubMed ID: 9666879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
    Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
    J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone status following treatment for Cushing's syndrome.
    Hughes NR; Lissett CA; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study.
    Vestergaard P; Jørgensen JO; Hagen C; Hoeck HC; Laurberg P; Rejnmark L; Brixen K; Weeke J; Andersen M; Conceicao FL; Nielsen TL; Mosekilde L
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):159-67. PubMed ID: 11874406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and late prognosis of cushing's syndrome: a population-based study.
    Lindholm J; Juul S; Jørgensen JO; Astrup J; Bjerre P; Feldt-Rasmussen U; Hagen C; Jørgensen J; Kosteljanetz M; Kristensen L; Laurberg P; Schmidt K; Weeke J
    J Clin Endocrinol Metab; 2001 Jan; 86(1):117-23. PubMed ID: 11231987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent improvement of bone mineral density up to 20 years after treatment of Cushing's syndrome.
    van Houten P; Netea-Maier R; Wagenmakers M; Roerink S; Hermus A; van de Ven A
    Eur J Endocrinol; 2021 Jul; 185(2):241-250. PubMed ID: 34061774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's syndrome and bone mineral density: lowest Z scores in young patients.
    van der Eerden AW; den Heijer M; Oyen WJ; Hermus AR
    Neth J Med; 2007 Apr; 65(4):137-41. PubMed ID: 17452762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Cushing's syndrome and cancer risk.
    Rudman Y; Fleseriu M; Dery L; Masri-Iraqi H; Sasson L; Shochat T; Kushnir S; Shimon I; Akirov A
    Eur J Endocrinol; 2024 Aug; 191(2):223-231. PubMed ID: 39067000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
    Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
    Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased pressor response to noradrenaline in pituitary dependent Cushing's syndrome.
    Heaney AP; Hunter SJ; Sheridan B; Brew Atkinson A
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):293-9. PubMed ID: 10469008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.